, and has also been found in some transformed B cell lines (2, 3). HTLV-I infection is associated with a profound increase in the number of cell surface interleukin 2 (I L-2) receptors (containing the Tac antigen) on infected T cells (1, 4). The ability of B lymphocytes to also express IL-2 receptors under certain conditions (2, 3, (5) (6) (7) , and the precise manner by which IL-2 affects B cell function, are areas of intense current interest (3, 5-8). Since we are interested in examining the effects of IL-2 on a homogeneous population of human B cells, we attempted to establish HTLV-I-infected, IL-2 receptor-positive B cell lines from normal human B cells. We show that HTLV-I can infect normal mature human B cells in vitro, and that IL-2 can affect these B cells, through their IL-2 receptor, to directly induce the differentiation of HTLV-I-infected B cells into Ig-secreting ceils, without affecting their proliferation.
Human T cell ieukemia/lymphoma virus (HTLV)-I can infect and transform normal T cells (1) , and has also been found in some transformed B cell lines (2, 3) . HTLV-I infection is associated with a profound increase in the number of cell surface interleukin 2 (I L-2) receptors (containing the Tac antigen) on infected T cells (1, 4) . The ability of B lymphocytes to also express IL-2 receptors under certain conditions (2, 3, (5) (6) (7) , and the precise manner by which IL-2 affects B cell function, are areas of intense current interest (3, (5) (6) (7) (8) . Since we are interested in examining the effects of IL-2 on a homogeneous population of human B cells, we attempted to establish HTLV-I-infected, IL-2 receptor-positive B cell lines from normal human B cells. We show that HTLV-I can infect normal mature human B cells in vitro, and that IL-2 can affect these B cells, through their IL-2 receptor, to directly induce the differentiation of HTLV-I-infected B cells into Ig-secreting ceils, without affecting their proliferation.
Materials and Methods

B Cell
Purification. Human tonsils were processed to obtain purified resting B cells using counterflow centrifugation elutriation (Model J-6B; Beckman Instruments, Inc., Palo Alto, CA) as previously described (6) . The smallest-sized B cell fractions (mean volume of 160-180 t~m 3) were >95% surface Ig-positive and <0.2% T3 ÷, as determined by fluorescence-activated cell sorter (FACS) analysis.
HTLV-I Infection. Cocultivation of the HTLV-I + B cell line, HS 1, a B cell clone isolated from a female patient with HTLV-associated adult T cell leukemia, with highly purified tonsillar small resting B cells was carried out as previously described (2). After 2 wk in culture, cell lines grew spontaneously and displayed growth in large clumps. Cell lines obtained from coculture of HS1 and unactivated B cells were called B-HTLV. After several weeks in culture, the cell line was examined for HLA phenotype and determination of HTLV infection. Cells infected with HTLV-1 were identified by indirect immunofluorescence using a monoclonal antibody (mAb) against p19, an HTLV-I-encoded protein in the cytoplasm of the infected cell, and by Southern blot hybridization using an HTLV-I pol-env-pX probe. Factors. Concanavalin A (Con A)-stimulated supernatant was prepared by coculturing peripheral blood mononuclear cells of two allogeneic donors in the presence of Con A (10 #g/ml). Purified IL-1 (Genzyme Corp., Boston, MA), recombinant IL-2 (Lot LP210; provided by Cetus Corp., Emeryville, CA), and recombinant ~,-interferon (I FN-7) (Genentech Corp., So. San Francisco, CA) were used in this study. B cell growth factor (BCGF) was derived from a B cell line, Namalva, as previously described (10).
Culture Conditions and Assays. HTLV-I-infected B cell lines or clones were cultured in 0.2 ml of RPMI-1640 supplemented with 10% fetal calf serum, and gentamicin (20 ttg/ml) in 96-well, flat-bottomed microtiter plates (3072; Falcon Labware, Oxnard, CA) at a cell density of 5 x 103 cells/well. Assays for proliferation and differentiation of cultured cells were done as previously described (6).
Results and Discussion
Development of HTLVoI-infected B Cell Clones In Vitro.
The cell surface characteristics of the cell lines used are listed in Table I . The newly established cell lines could be distinguished from HS1 by differences in sex chromosomes and HLA antigens, HS1 was isolated from a female patient, and expressed HLA-DR3, MT1, and MT2. The new cell lines (B-HTLV, and STB-1) contained a Y chromosome, and expressed HLA-DR6, DR10, MT1, and MT2. These cell lines expressed B ceil-associated antigens, surface Ig and Leu-12, but neither of the T cell markers, Leu-1 nor T3. They also expressed the HTLV-encoded viral protein, p19, in their cytoplasm. In addition, we determined whether STB-1 cells were infected with HTLV-I by Southern blot hybridization (Fig. 1) . When DNA from the ceils were digested with Barn HI and hybridized with HTLV-I pol-env-pX probe, three distinct bands and three thin bands, which contained Barn H I j u n c t i o n fragments, were obtained, indicating that three copies o f H T L V -I were integrated in this population. A distinct b a n d o f 1.1 kilobases (kb) was also observed, which is c o m m o n to all H T L V -I -i n f e c t e d cells, a n d represents an internal f r a g m e n t o f the provirus. This indicates that there is not a large internal deletion o f the proviruses in STB-1 cells. Digestion with Pst I resulted in the internal f r a g m e n t o f 2.5 kb and three j u n c t i o n fragments, c o n f i r m i n g that three oligoclonal proviral integrations took place in this population. The new cell lines were also tested for Epstein-Barr virus (EBV) infection, as determined by the presence of Epstein-Barr nuclear antigen (EBNA). Some cells of each cell line expressed a small amount of EBNA. However, at the time we infected the small B cells with HTLV-I, EBNA was undetectable. Thus, they still were "normal" B cells at the time they became transformed with HTLV-I. Nonactivated small resting B cells are negative for Tac antigen, whereas in vitro-activated B cells do express Tac antigen on their surface (3, 5-7). As shown in Table I (1, 4) . This suggests that HTLV may either upregulate the expression of Tac antigen on infected cells, or may itself produce a protein, similar or identical to the Tac antigen, that becomes expressed on the cell surface, but there is little evidence for HTLV-I encoding a Tac-like antigen (11) . Nevertheless, the possibility that HTLV-I selectively infected a small number of already Tac + cells cannot be ruled out by this study.
Responses of HTL V-I-infected B Cells to Various Lymphokines.
To determine the effect of various lymphokines on HTLV-I-infected B cells, cells were incubated at 5 × 10 a cells/well with a variety of lymphokines, after which DNA synthesis and Ig production were measured (Table II) . HS 1 cells spontaneously produced IgM, but not IgG or IgA, in the absence of lymphokines.This cell line could be induced to produce additional IgM by Con A supernatant (containing a variety of iymphokines, including IL-2 and B cell differentiation factor). Low concentrations (25 U/ml) of IL-2 had little effect on the proliferation and differentiation of HS1. The new lines, B-HTLV and STB-1, had a relatively low background secretion of IgM, and virtually no background secretion of IgG or IgA. However, B-HTLV responded well to IL-2 with an eightfold enhanced secretion of IgM. The same was true of STB-1, which secreted IgM in response to IL-2 to a greater degree than to the other lymphokines tested. IL-2 did not enhance the proliferation of these B cells at any concentration tested (0.8-100 U/ml). The IL-2-induced differentiation of STB-1 cells was notably inhibited, in a concentration-dependent manner, by the addition to culture of anti-Tac antibody, but not by control ascites (P3X63) (Fig. 2 B) . In addition, anti-Tac antibody had no effect on the background proliferation of STB-1 cells (data not shown). These data suggest that Tac antigen found on the HTLV-I-infected B cell clone STB-1 has functional importance in the IL-2-induced differentiation of this clone.
The interaction beween IL-2 and its receptor on B cells is of interest. Ralph et al. (8) shows that Tac antigen was not involved in the IL-2-induced differentiation of EBV-transformed B cells. However, as Waldmann et al. (3) have shown, EBV-transformed B cell lines derived from Tac +, activated normal B cells continued to express Tac antigen, and were induced to differentiate by the addition of IL-2. In addition, Tsudo et al. (5) suggested that IL-2 induced the proliferation of normal activated B cells via the IL-2 receptor, as defined by the Tac antigen. These observations, taken in conjunction with this study, suggest that the IL-2 receptor is induced in certain subsets of B ceils, or B cells at certain stages of differentiation, and that IL-2 can perform an important role in B cell maturation through its receptor. Furthermore, HTLV-I, different from EBV, may induce B cells to respond to IL-2 by inducing the expression of the IL-2 receptor. However, it is still not clear whether the IL-2 receptor is somehow closely associated with a differentiation receptor, or whether IL-2, acting through its own receptor on the responding cell, provides a second late differentiation or secretion signal.
Summary
A human T cell leukemia/lymphoma virus (HTLV)-I-infected B cell clone expressed Tac antigen on its cell surface and responded to recombinant interleukin 2 (IL-2) by increased production of IgM without any increase in proliferation. Anti-Tac antibody completely inhibited the IL-2-induced differentiation of this HTLV-I-infected B cell clone. This study demonstrates that HTLV-I can directly infect normal mature human B cells, and that the Tac antigen, which may be induced by infection with HTLV-I, is the functional receptor for IL-2-induced B cell differentiation. The availability of such cell lines and clones should provide useful tools to delineate precisely the differentiation step in the human B cell cycle.
